199 related articles for article (PubMed ID: 22446173)
1. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.
Yu L; Boulware DC; Beam CA; Hutton JC; Wenzlau JM; Greenbaum CJ; Bingley PJ; Krischer JP; Sosenko JM; Skyler JS; Eisenbarth GS; Mahon JL;
Diabetes Care; 2012 Jun; 35(6):1213-8. PubMed ID: 22446173
[TBL] [Abstract][Full Text] [Related]
2. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
3. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort.
Long AE; Gooneratne AT; Rokni S; Williams AJ; Bingley PJ
J Clin Endocrinol Metab; 2012 Feb; 97(2):632-7. PubMed ID: 22162482
[TBL] [Abstract][Full Text] [Related]
4. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.
De Grijse J; Asanghanwa M; Nouthe B; Albrecher N; Goubert P; Vermeulen I; Van Der Meeren S; Decochez K; Weets I; Keymeulen B; Lampasona V; Wenzlau J; Hutton JC; Pipeleers D; Gorus FK;
Diabetologia; 2010 Mar; 53(3):517-24. PubMed ID: 20091020
[TBL] [Abstract][Full Text] [Related]
5. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
[TBL] [Abstract][Full Text] [Related]
7. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
[TBL] [Abstract][Full Text] [Related]
8. Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.
Vermeulen I; Weets I; Asanghanwa M; Ruige J; Van Gaal L; Mathieu C; Keymeulen B; Lampasona V; Wenzlau JM; Hutton JC; Pipeleers DG; Gorus FK;
Diabetes Care; 2011 Aug; 34(8):1760-5. PubMed ID: 21715527
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
[TBL] [Abstract][Full Text] [Related]
10. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583
[TBL] [Abstract][Full Text] [Related]
11. Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases.
Howson JM; Krause S; Stevens H; Smyth DJ; Wenzlau JM; Bonifacio E; Hutton J; Ziegler AG; Todd JA; Achenbach P
Diabetologia; 2012 Jul; 55(7):1978-84. PubMed ID: 22526605
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
13. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.
Maclaren N; Lan M; Coutant R; Schatz D; Silverstein J; Muir A; Clare-Salzer M; She JX; Malone J; Crockett S; Schwartz S; Quattrin T; DeSilva M; Vander Vegt P; Notkins A; Krischer J
J Autoimmun; 1999 Jun; 12(4):279-87. PubMed ID: 10330299
[TBL] [Abstract][Full Text] [Related]
14. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.
Andersson C; Larsson K; Vaziri-Sani F; Lynch K; Carlsson A; Cedervall E; Jönsson B; Neiderud J; Månsson M; Nilsson A; Lernmark A; Elding Larsson H; Ivarsson SA
Autoimmunity; 2011 Aug; 44(5):394-405. PubMed ID: 21244337
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
[TBL] [Abstract][Full Text] [Related]
16. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
[TBL] [Abstract][Full Text] [Related]
17. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
19. Positivity for Zinc Transporter 8 Autoantibodies at Diagnosis Is Subsequently Associated With Reduced β-Cell Function and Higher Exogenous Insulin Requirement in Children and Adolescents With Type 1 Diabetes.
Juusola M; Parkkola A; Härkönen T; Siljander H; Ilonen J; Åkerblom HK; Knip M;
Diabetes Care; 2016 Jan; 39(1):118-21. PubMed ID: 26519333
[TBL] [Abstract][Full Text] [Related]
20. Distribution of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8 in type 1 diabetes and latent autoimmune diabetes: A nationwide, multicentre, cross-sectional study.
Fan W; Nan X; Peng Y; Li X; Xiang Y; Yan X; Xie Z; Zhou H; Tang X; Cheng J; Niu X; Liu J; Ji Q; Ji L; Huang G; Zhou Z
Diabetes Metab Res Rev; 2023 Feb; 39(2):e3592. PubMed ID: 36401613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
